H-ILRKLLQE-OH
Rif. 3D-PP46217
1mg | 202,00 € | ||
10mg | 234,00 € | ||
100mg | 412,00 € |
Informazioni sul prodotto
- NH2-Ile-Leu-Arg-Lys-Leu-Leu-Gln-Glu-OH
Peptide H-ILRKLLQE-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ILRKLLQE-OH include the following: Circulation Americanean Re S a arch Learn and Live. Y Sato, R Nakamura, M Satoh, K Fujishita, S Mori - 2005 - mhlw-grants.niph.go.jphttps://mhlw-grants.niph.go.jp/system/files/2005/058051/200501076A/200501076A0003.pdf 5alpha-Bile alcohols function as farnesoid X receptor antagonists T Nishimaki-Mogami, Y Kawahara, N Tamehiro - Biochemical and , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X05025416 The RXR agonists PA024 and HX630 have different abilities to activate LXR/RXR and to induce ABCA1 expression in macrophage cell lines T Nishimaki-Mogami, N Tamehiro, Y Sato - Biochemical , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295208005340 Pregnane X receptor in drug development S Ong, Y Wang , S Chai , T Chen - Drug Development-A Case , 2011 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=K9mgDwAAQBAJ&oi=fnd&pg=PA337&dq=(%22H-ILRKLLQE-OH%22+OR+%22NH2-Ile-Leu-Arg-Lys-Leu-Leu-Gln-Glu-OH%22+OR+%22ILRKLLQE%22)+AND+peptide&ots=iYsvjC5-2_&sig=y4q_eDQRdPH6teG1nhx4ST7kf18 Riccardin C: A natural product that functions as a liver X receptor (LXR) alpha agonist and an LXRbeta antagonist N Tamehiro, Y Sato, T Suzuki, T Hashimoto - FEBS letters, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014579305010665 Role of LXRs in control of lipogenesis JR Schultz, H Tu, A Luk, JJ Repa - Genes & , 2000 - genesdev.cshlp.orghttps://genesdev.cshlp.org/content/14/22/2831.short Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the J Ou, H Tu, B Shan, A Luk - Proceedings of the , 2001 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.111138698 Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha BB Busch , WC Stevens, R Martin - Journal of medicinal , 2004 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm049334f Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor B Goodwin, KC Gauthier, M Umetani - Proceedings of the , 2003 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0237082100 Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding AL Rodriguez, A Tamrazi , ML Collins - Journal of medicinal , 2004 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm030404c Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor AL LaFrate, JR Gunther, KE Carlson - Bioorganic & medicinal , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0968089608009450 匷å¿ÆéâŠÂç³âÀœâacaâ¢acaâ°acaƪacaâ³acaƳaca§acaÂâacaââ¹acaâžacaâÂŽacaâÂacaâ·acaâ²acaÆâ¹acaƳaca® LXR éžʊşçšâacaâ¢acaƳacaâ¿acaâÂŽacaÆâ¹acaâ¹acaÆËʎ»Êâ¬Â§aca®çâ¢ÂºÃšÂŠâ¹ å€https://tohoku.repo.nii.ac.jp/?action=repository_uri&item_id=123641&file_id=18&file_no=1 Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation A Tamrazi , KE Carlson, AL Rodriguez - Molecular , 2005 - academic.oup.comhttps://academic.oup.com/mend/article-abstract/19/6/1516/2737993
Proprietà chimiche
Richiesta tecnica su: 3D-PP46217 H-ILRKLLQE-OH
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.